Gregory C Henderson
Purdue University West Lafayette (Department of Nutrition Science), Indiana, USA
The Henderson laboratory studies the metabolic control of lipid release and uptake from tissues and the implications for metabolic health. Through studies of lipid metabolism at a biochemical level and in vivo, lifestyle factors such as exercise and diet are also addressed. Specifically, the team studies responses of free fatty acid mobilization, lipoprotein kinetics, and accumulation of various lipids within tissues such as the liver. The overall goal is to understand how lipid metabolism responds to physiological stressors, as well as to elucidate the relationship between fatty acid metabolism and health.
The University of Alabama at Birmingham (UAB), Birmingham, USA
Dr. Parmanand Malvi received his PhD degree in Biotechnology from National Centre for Cell Science (NCCS), Pune, India affiliated to Savitribai Phule Pune University (SPPU), Pune, India. Currently, Dr. Malvi is pursuing his research as a Postdoctoral Fellow at the University of Alabama at Birmingham (UAB), Birmingham, USA. Before joining the UAB, he worked as a Postdoctoral Associate for 3.5 years at Yale University, New Haven, USA. His research interests include Cancer Cell Metabolism, Functional Genomics, Signal Transduction, Drug Resistance in Cancer, Adipocyte Biology, and Connections between Metabolic Diseases (such as Obesity and Diabetes) and Cancer.
Cleveland Clinic Foundation (Lerner Research Institute), Cleveland, USA
"I carried out my doctoral research at the Indian Institute of Science, Bangalore, India in the field of mitochondrial dysfunction associated with heart failure, muscle fatigue, and neurodegenerative disorders. Presently, I am doing my research at the Cleveland Clinic, Ohio, USA, in the field of gut-microbiome and cardiovascular disease (CVD) with a special interest in understanding dysregulated cell signaling linked to atherosclerosis and diabetes. My research interest includes delineating G-protein coupled receptors (GPCRs) signaling pathways specifically via adrenergic receptors in heart failure and hypertension. We are focused on identifying novel cellular target receptors of human gut microbe derived metabolites pathologically linked to CVD. Identification of receptors of novel CVD linked gut-microbial metabolite would be remarkable in cardiovascular biology as they can be used as therapeutic targets."